LIVER DISEASES

This study aimed to find the best surgical tool for connecting bile ducts during living donor liver transplants. Researchers compared using a high-powered microscope to standard surgical magnifying glasses (loupes) in 52 patients. The goal was to see which method led to fewer bil…

This study tested a new medical patch called GATT-Patch against a standard patch (TachoSil) to see which works better at stopping bleeding during planned open liver surgery. It involved 132 patients who had minimal to moderate bleeding that standard techniques couldn't easily con…

This study tested a new medical patch called GATT-Patch, designed to stop bleeding during minimally invasive liver and gallbladder surgeries. It was compared directly to a commonly used product, SURGICEL® Original. The main goal was to see if the new patch could control minimal t…

This study aimed to develop a new test that analyzes chemicals in a person's breath to help diagnose diseases. Researchers collected breath samples from 46 people, including healthy volunteers and patients with liver disease or COVID-19. The goal was to see if unique breath 'fing…

This study tested how consistent and reliable a special type of MRI scan, called LiverMultiScan, is for measuring liver health. Researchers scanned 61 volunteers with various liver conditions on different MRI machines to see if the results were the same each time. The goal is to …

This early-stage study looked at how a single dose of an experimental drug called etavopivat is processed by the body in people with different levels of liver function. It involved 48 adults, some with stable liver disease and some with healthy livers, to compare drug levels and …

This study tested a new program called GRACE, designed to help primary care clinics identify patients at high genetic risk for serious diseases like heart disease and cancer. About 750 patients used a website to enter their family health history, which then recommended if they ne…

This study aims to understand how liver disease changes the way the body processes an experimental cancer drug called sevabertinib. Researchers compared about 20 people—half with moderate liver problems and half with healthy livers—after each took a single dose. By measuring drug…